drugset / Trial / NCT05095558
Microtransplantation for Ovarian Cancer
Phase 1/2
Unknown
60 enrolled
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Non-randomizedSingle-groupOpen-labelTreatment
Summary
In this study, we will apply micro transplantation to the field of recurrent and advanced ovarian cancer to study the efficacy and safety.
Timeline
- Start
- 2021-10-01
- Primary completion
- 2023-10-31
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HLA-mismatched peripheral blood stem cells | Cell therapy | — | — |